__NUXT_JSONP__("/drugs/Ficlatuzumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1174900-84-5",chebiId:b,chemicalFormula:b,definition:"A humanized monoclonal antibody directed against human hepatocyte growth factor (HGF) with potential antineoplastic activity. Ficlatuzumab binds to the soluble ligand HGF, preventing the binding of HGF to its receptor c-Met and activation of the HGF\u002Fc-Met signaling pathway, which may result in cell death in c-Met-expressing tumor cells. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays a key role in cancer cell growth, survival, angiogenesis, invasion, and metastasis.",fdaUniiCode:"77E89833TG",identifier:"C78844",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129822","C20401"],synonyms:["AV-299","Anti-HGF Monoclonal Antibody SCH900105","FICLATUZUMAB",a,"SCH 900105"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FFiclatuzumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Ficlatuzumab","","2021-10-30T13:45:19.793Z")));